Company intelligence / Profile preview

Maersk

Ownership: Public · MAERSK B
Employees: ~88000
Development stage: Other

Overview

Maersk is a global leader in integrated container shipping and logistics with specialized expertise in pharmaceutical and healthcare supply chains. The company offers end-to-end cold chain management solutions compliant with GDP standards to ensure the integrity of temperature-sensitive products such as biologics and vaccines during global transport. It partners with leading pharma companies to provide reliable delivery while supporting decarbonization goals through ocean-based cold chain alternatives to air freight.

Industry: Drug Discovery Services

Partnerships

Bayer (20-year innovation alliance in pharma/agriculture supply chains)Novo Nordisk (decarbonized supply chain partnership)Pharma.Aero collaboration for advancing pharmaceutical logistics

Financials

Market cap: $224M
Total revenue: $0
Enterprise value: $-21.1M

Beyond the preview

Go deeper on Maersk.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Maersk.

Explore the full profile